FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/13/2023
Back to search
Official data from USPTO
ALBAJUNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALBAJUNA
ST13
US500000079326559Class
5, 41, 42, 44
Filing
79326559
Registration
6982504
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
06/13/2023
Trademark type
Word
Nice classes
5, 41, 42, 44
Filing date
09/22/2021
Registration date
02/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/21/2023
Last transaction
02/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
ES
Examiner
TULLY, MATTHEW
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ALBAJUNA THERAPEUTICS, S.L.
Representatives
Ashly I. Boesche Pattishall, McAuliffe, Newbury, Hilliard
Technical classification
Nice Classes
Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsrecombinant therapeutics for the treatment of HIV/AIDS; biological preparations for medical userecombinant therapeutics for the treatment of HIV/AIDS; antiviral preparationsrecombinant therapeutics being pharmaceutical preparations in the nature of antivirals; pharmaceutical products for the treatment of HIV/AIDS; chemicalanalysis and diagnostic reagents for medical research and for medical and veterinary use in diagnostics; diagnosis preparations for medical purposesmedical diagnostic reagents; diagnostic testing materials for medical usediagnostic kits comprised of medical diagnostic recombinant reagents and assays for detecting diseases
Class 41
Educational servicesproviding training in the field of medical and pharmaceutical products; organization and conducting of seminarsconferencescongressessymposiums and training workshops in the field of medical and pharmaceutical products; online publication of books and journals in the field of medical and pharmaceutical products in electronic formbeing publishing services; practical training in the field of medicine and pharmaceutical products; publication of texts other than advertising texts in the field of medicine and pharmaceutical products
Class 42
Pharmaceutical research and development; medical research in the field of recombinant therapeutics; clinical research services in the field of pharmaceuticalsrecombinant therapeutics; laboratory research services relating to pharmaceuticals; research and development services relating to new pharmaceutical products; laboratory materials analysis services being medical and scientific laboratory services; chemical analysis; scientific laboratory services; laboratory testing servicesmedical and scientific laboratory services; medical research laboratory services; research and development services relating to pharmaceutical substances; technical consultancy in the pharmaceutical sectorconsulting services in the field of pharmaceutical research and development; online and in-person information and advisory services relating to the aforesaid
Class 44
Monitoring of patientsmonitoring of medical data for medical diagnosis and treatment; advice in the field of beauty care; psychological assistance for patients; providing medical and health information about medical disorders; providing medical and health information about infection control; medical services for psychological counseling; patient support services in the nature of medical services relating to the treatment of medical disorders; medical services; providing health information; information and advisory services relating to pharmaceutical productsmedical and pharmaceutical consultation; online and in-person information and advisory services relating to the aforesaid
Publications
History of USPTO decisions and trademark events.
38 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/24/2023
FIMP
FINAL DISPOSITION PROCESSED
05/24/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/21/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/21/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/06/2022
PUBO
PUBLISHED FOR OPPOSITION
12/06/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/23/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/23/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/02/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/02/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/02/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/02/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/02/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/20/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/06/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/06/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/06/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/06/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/25/2022
RFNT
REFUSAL PROCESSED BY IB
07/26/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/01/2022
RFRR
REFUSAL PROCESSED BY MPU
07/01/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/29/2022
CNRT
NON-FINAL ACTION WRITTEN
06/28/2022
DOCK
ASSIGNED TO EXAMINER
06/24/2022
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/15/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/29/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/25/2021
Continuous trademark protection
Get notified about every new filing that threatens ALBAJUNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.